Are biostimulatory fillers and hyaluronic acid fillers the same?

Hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), PMMA and other injectables differ in carrier, particles, tissue response, onset, persistence and complication management. A claim that a product stimulates collagen cannot replace product identity or an assessment of suitability.

This translation has no recorded clinical or medical-language review.

Direct answer

Hyaluronidase used for HA is not a universal antidote for particulate or biostimulatory products.
Immediate volume and a tissue response developing over time require different outcome and follow-up models.
Even products in one material class may differ in rheology, concentration and authorized treatment areas.

Why material behaviour matters

HA gels provide volume and shape through water interaction, cross-linking and viscoelastic properties, and their formulations are not interchangeable. Products such as CaHA and PLLA may combine a carrier effect with a cellular and foreign-body response that develops over time. Permanent particles such as PMMA have a different timeline and different limits on removal.

Dissolution and reversibility are not the same

HA can be broken down with hyaluronidase in selected circumstances, but the result depends on dose, location, timing and complication type. CaHA, PLLA, PMMA and silicone do not dissolve with the same enzyme. Gradual biodegradation also does not mean that a product can be easily reversed in an emergency. A patient card and lot record are therefore important for later care.

How to discuss product choice

First define the anatomical target, skin and tissue thickness, previous materials, desired timeline and risk tolerance. Then review the exact product, Turkish registration and indication, planned depth and volume, follow-up and possible complication response. Popularity or longer duration in one class is not proof of superiority or a guarantee of personal benefit.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Dermal Fillers (Soft Tissue Fillers)
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Microneedling for Facial Rejuvenation: A Systematic Review
Foppiani JA et al. · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Evaluating the Effectiveness and Safety of Radiofrequency for Face and Neck Rejuvenation: A Systematic Review
Austin GK, Struble SL, Quatela VC · 2022
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Energy-Based Devices for the Treatment of Facial Skin Conditions in Skin of Color
Sanyal RD, Fabi SG · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling – FDA Safety Communication
U.S. Food and Drug Administration (FDA) · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Manufacturing Process of Hyaluronic Acid Dermal Fillers
Review authors; Aesthetic Plastic Surgery · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Late-Onset Reactions after Hyaluronic Acid Dermal Fillers: A Consensus Recommendation
CARE board consensus authors · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review